AKTS · Aktis Oncology, Inc.
$24.00
-1.02 (-4.08%)
At close · Aug 20
Market Cap
$1.33B
Shares
55.62M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Oleg Nodelman | member of the Board and all committees thereof | Resigned | 2026-04-16 |
| Helen S. Kim | member of the Board and all committees thereof | Resigned | 2026-04-16 |
| Glenn Gormley | Class I director | Appointed | 2026-04-16 |
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
105 filings
105 filers
Visit website
Investor relations